Elevated stress hyperglycemia and the presence of intracranial artery stenosis increase the risk of recurrent stroke
Frontiers in Endocrinology · 2023
DOI: 10.3389/fendo.2022.954916 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Yongle Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Hyperglycemia, Intracranial Arteriosclerosis, Ischemic Stroke. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Stress hyperglycemia has served as a reliable biomarker to predict poor outcomes after ischemic stroke. However, recent studies have reported some contrary conclusions. Different stroke subtypes may respond inconsistently to stress hyperglycemia. The progression of intracranial atherosclerotic stenosis (ICAS) is tightly related to hyperglycemia. Thus, this study aims to determine the relationship between stress hyperglycemia and recurrent stroke in ischemic stroke patients with or without intracranial atherosclerotic stenosis.
Methods
This is a multicenter retrospective observational cohort study. Patients with acute minor ischemic stroke and eligible computed tomography and magnetic resonance imaging data were enrolled. The severity of stress hyperglycemia is measured by the stress hyperglycemia ratio (SHR). SHR was calculated based on fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) levels. The primary outcome was stroke recurrence during hospitalization. The interaction of SHR levels with the presence of ICAS on the primary outcome was investigated using univariable and multivariable Cox proportional hazards models. Restricted cubic splines were applied to determine the nonlinear relationship between SHR and primary outcome. A two-piecewise linear regression model was used to identify the threshold of SHR.
Results
A total of 610 participants were included in the study. The average age of the patients was 61.4 ± 12.9 years old, and approximately 70% of participants were males. A total of 189 (30.98%) patients had ICAS. The patients were categorized into 3 groups based on the tertiles of SHR. Compared with the group with a lower SHR, a higher SHR was significantly associated with the risk of stroke recurrence in the ICAS group (hazard ratio [HR], 8.52, 95% confidence interval [CI], 3.16-22.96, P<0.001). When SHR was treated as a continuous variable, each 0.1-unit increase in SHR in the ICAS group was associated with a 1.63-fold increase in the risk of recurrence (HR, 1.63, 95% CI, 1.39-1.9, P<0.001) with a threshold of 0.75. FPG but not HbA1c was associated with stroke recurrence in ICAS patients (HR, 1.17, 95% CI, 1.08-1.26, P<0.001). Sensitive analyses showed consistent results after adjusting for previous diabetes mellitus, oral hypoglycemic agents and insulin injection.
Conclusions
SHR represents a better biomarker to predict the risk of stroke recurrence in patients with ICAS than FPG and HbA1c regardless of previous diabetes mellitus. Trial registration https://www.chictr.org.cn/showproj.aspx?proj=125817 ; Identifier, [ChiCTR2100046958].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- Clinical College, Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Neurology, The Bethune Hospital of Shanxi Province, Taiyuan, Shanxi, China.
- Department of Neurology, Sixth Hospital of Shanxi Medical University (General Hospital of Tisco), Taiyuan, Shanxi, China.
Zitieren
APA
Wang, Y., Fan, H., Duan, W., Ren, Z., Liu, X., Liu, T., Li, Y., Zhang, K., Fan, H., Ren, J., Li, J., Li, X., Wu, X., & Niu, X. (2023). Elevated stress hyperglycemia and the presence of intracranial artery stenosis increase the risk of recurrent stroke. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2022.954916
Vancouver
Wang Y, Fan H, Duan W, Ren Z, Liu X, Liu T, et al. Elevated stress hyperglycemia and the presence of intracranial artery stenosis increase the risk of recurrent stroke. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2022.954916
BibTeX
@article{Wang2023,
author = {Wang, Yongle and Fan, Hongxuan and Duan, Weiying and Ren, Zhaoyu and Liu, Xuchang and Liu, Tingting and Li, Yanan and Zhang, Kaili and Fan, Haimei and Ren, Jing and Li, Juan and Li, Xinyi and Wu, Xuemei and Niu, Xiaoyuan},
title = {Elevated stress hyperglycemia and the presence of intracranial artery stenosis increase the risk of recurrent stroke},
journal = {Frontiers in Endocrinology},
year = {2023},
doi = {10.3389/fendo.2022.954916}
}
EUVIMED